Clinical Trial Update: Mass Spectral Fingerprinting in Lung Cancer

View source ↗

Summary

An active, not recruiting clinical trial at the University of Zurich is exploring mass spectral fingerprinting in lung cancer. The study is not currently enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Zurich | Conditions: Lung Cancer | Status: ACTIVE_NOT_RECRUITING